SAN DIEGO -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received a non-binding proposal from Deerfield Management Company, L.P. and certain affiliated funds (collectively, “Deerfield”), to acquire all of the Company’s outstanding shares of common [...]

FREMONT, Calif. -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Chief Operating Officer, Chris Williams, will resign his position effective September 27, 2024, to accept a CEO position at another company. Cytek has chosen not to replace the COO position, opting instead to restructure the organization to [...]

Advancing structural biology research with the GenNext AutoFox® Protein Footprinting System and Agilent 6560 Ion Mobility Quadrupole Time-of-Flight (IM-QTOF) LC/MS system Caption: GenNext and Agilent announced a pioneering collaboration for structural biology research. Half Moon Bay, CA – Today at CASSSS 2024, GenNext Technologies and Agilent announced a pioneering collaboration that promises to transform structural [...]

Collaboration Aims to Harness HiFi Sequencing to Improve Diagnosis and Treatment of Subfertility and Recurrent Pregnancy Loss SINGAPORE -- The HiFi Solves Sub-fertility Consortium, an innovative collaboration involving five leading centers across the Asia-Pacific region, announces work aimed at redefining the landscape of fertility research. Utilizing PacBio HiFi long-read sequencing, the consortium, led by KK [...]

Introducing HALO® OLIGO C18 Columns: Setting New Standards in Oligonucleotide Separations Wilmington, DE —Advanced Materials Technology (AMT), a leading innovator in chromatography solutions, proudly announces the launch of its latest product, the HALO® OLIGO C18 columns, engineered to deliver exceptional performance in oligonucleotide separations. Built upon advanced Fused-Core® particle technology and incorporating innovative surface modified organo-silane [...]

Shimadzu Corporation, DKS Co., Ltd. (Kyoto City, hereinafter DKS), and Professor Shigeo Horie of Graduate School of Medicine, Juntendo University signed a technical partnership agreement regarding techniques used to identify functional properties of biologically active substances contained in foods and pharmaceuticals. The technical partnership will research Cordyceps sinensis, a “caterpillar fungus” obtained using a proprietary [...]

In 2024, Shimadzu Corporation started SPARK* (hereinafter, “this system”), a system to support employees acquiring doctorates by encouraging both their doctoral studies and routine work activities. This system supports the acquisition of university degrees by those interested in obtaining a doctorate where their domain of research from a work strategy perspective fits with the theme of [...]

DKSH has formed a strategic partnership with NanoCellect Biomedical, a manufacturer of unique cartridge-based cell sorters and image-guided cell analyzers and sorters. DKSH will leverage its expertise and global experience to enhance NanoCellect’s business opportunities in six new markets in Southeast Asia. Bangkok – DKSH Business Unit Technology has formed a partnership with NanoCellect Biomedical, [...]

MARIETTA, Ohio -- Caron Products and Services, Inc., a leading provider of laboratory equipment for drug development, cell and gene therapy research, and academic research, is pleased to announce its brand unification and the launch of a newly redesigned website, updated logo, and new company URL: https://caronscientific.com. This milestone reflects the company's commitment to aligning [...]

BOSTON -- Volta Labs, a genomics applications company, announced today that the Callisto™ Sample Prep System has begun shipping to the first set of customers, with the first instrument going to the Icahn School of Medicine at Mount Sinai. "As an early collaborator with Volta, we had the opportunity to observe the capabilities and speed of this [...]